14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EXAS ranks #11496 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

EXACT Sciences Corporation Stock Forecast NASDAQ:EXAS

$86.26 (3.48%)

Volume: 2M

Closed: Dec 08, 2021

Hollow Logo Score: -1.682

EXACT Sciences Corporation Stock Forecast

$86.26 (3.48%)

Volume: 2M

Closed: Dec 08, 2021

Score Hollow Logo -1.682

EXACT Sciences Corporation Stock Forecast NASDAQ:EXAS

Price Target and Analyst Ratings

Most Recent Rating

On Nov 03, 2021 "SVB Leerink" gave "$160.00 - $140.00" rating for EXAS. The price target was changed from $92.86 to 2.9%.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-11-03 $160.00 - $140.00 Target Lowered by SVB Leerink $94.32 $92.86→2.9%
2021-11-03 $120.00 - $95.00 Target Lowered by Wells Fargo & Company $94.32 $92.86→2.9%
2021-11-03 $125.00 - $116.00 Target Lowered by Robert W. Baird $94.32 $92.86→2.9%
2021-11-03 $160.00 - $130.00 Downgraded by Raymond James $94.32 $92.86→2.9%
2021-11-03 $144.00 - $133.00 Target Lowered by Craig Hallum $94.32 $92.86→2.9%
2021-11-03 $145.00 - $120.00 Target Lowered by BTIG Research $94.32 $92.86→2.9%
2021-10-14 $160.00 - $135.00 Target Lowered by Cowen $97.75 $97.75+0.4%
2021-07-29 $155.00 - $145.00 Reiterated by BTIG Research $111.91 $112.36→3.2%
2021-07-29 $157.00 - $127.00 Target Lowered by Robert W. Baird $111.91 $116.06+3.7%
2021-07-29 $185.00 - $160.00 Target Lowered by Canaccord Genuity $111.91 $116.06+3.7%
2021-07-29 $161.00 - $155.00 Target Lowered by Oppenheimer $111.91 $116.06+3.7%
2021-07-29 $155.00 - $145.00 Target Lowered by BTIG Research $111.91 $116.06+3.7%
2021-07-29 $165.00 - $145.00 Target Lowered by Stifel Nicolaus $111.91 $116.06+3.7%
2021-07-14 $170.00 - $160.00 Target Lowered by SVB Leerink $110.54 $114.48→1.5%
2021-06-21 Equal Weight Target Raised by Wells Fargo & Company $127.66 $115.00 → $120.00
2021-06-15 Strong-Buy Initiated by Raymond James $122.57
2021-06-15 Strong-Buy Initiated by Raymond James $122.57 $160.00
2021-06-03 Buy Initiated by The Goldman Sachs Group $107.91 $160.00
2021-05-25 Equal Weight Initiated by Wells Fargo & Company $109.88 $115.00
2021-05-18 Buy Target Lowered by Truist Securities $96.58 $226.00 → $168.00
2021-05-12 Buy Target Lowered by Truist Securities $96.11 $226.00 → $168.00
2021-05-12 Target Lowered by Truist $96.11 $226.00 → $168.00
2021-05-11 Outperform Target Lowered by SVB Leerink $98.00 $180.00 → $170.00
2021-05-05 Buy Target Lowered by BTIG Research $110.65 $175.00 → $155.00
2021-05-05 Outperform Target Lowered by SVB Leerink $110.65 $180.00 → $170.00
2021-05-05 Buy Target Lowered by Craig Hallum $110.65 $161.00 → $144.00
2021-02-18 Outperform Target Lowered by Robert W. Baird $141.65 $169.00 → $163.00
2021-02-17 Market Perform - Outperform Target Raised by SVB Leerink $140.99 $170.00 → $180.00
2021-02-17 Outperform Target Raised by Cowen $140.99 $154.00 → $180.00
2021-02-17 Buy Target Raised by Stifel Nicolaus $140.99 $150.00 → $165.00
2021-01-27 Buy Initiated by Truist $136.85
2021-01-27 Buy Initiated by Truist $136.85 $226.00
2021-01-21 Outperform Target Raised by SVB Leerink $148.07 $160.00 → $170.00
2021-01-12 Buy Target Raised by Canaccord Genuity $148.42 $160.00 → $165.00
2020-10-29 Buy - Neutral Downgraded by UBS Group $120.51 $125.00 → $140.00
2020-10-28 Buy - Neutral Downgraded by Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell $127.52 $120.00 → $140.00
2020-10-28 Buy Target Raised by Benchmark $127.52 $110.00 → $145.00
2020-10-28 Positive - Outperform Target Raised by Robert W. Baird $127.52 $135.00 → $150.00
2020-10-28 Outperform Target Raised by SVB Leerink $127.52 $115.00 → $160.00
2020-10-28 Buy - Neutral Downgraded by Smith Barney Citigroup $127.52 $120.00 → $140.00
2020-10-28 Target Raised by BTIG Research $127.52 $140.00 → $155.00
2020-10-28 Target Raised by Oppenheimer $127.52 $115.00 → $150.00
2020-10-28 Buy Target Raised by Canaccord Genuity $127.52 $120.00 → $145.00
2020-09-25 Buy Target Raised by Canaccord Genuity $97.70 $115.00 → $120.00
2020-07-31 Outperform Target Raised by SVB Leerink $94.75 $90.00 → $115.00
2020-07-31 Buy Target Raised by Citigroup $94.75 $110.00 → $120.00
2020-07-31 Buy Target Raised by Benchmark $94.75 $90.00 → $110.00
2020-07-08 Buy Reiterated by Oppenheimer $91.66
2020-06-25 Buy Target Raised by Citigroup $83.88 $100.00 → $110.00
2020-05-07 Buy Target Lowered by Canaccord Genuity $82.85 $120.00 → $110.00
2020-05-07 Outperform Target Lowered by SVB Leerink $82.85 $100.00 → $90.00
2020-05-07 In-Line - Buy Target Lowered by Craig Hallum $82.85 $99.00 → $92.00
2020-05-07 Buy Target Raised by Bank of America $82.85 $88.00 → $94.00
2020-05-07 Outperform Target Raised by Robert W. Baird $82.85 $90.00 → $92.00
2020-04-28 Buy Target Lowered by UBS Group $77.17 $135.00 → $115.00
2020-04-22 Outperform Target Lowered by Robert W. Baird $74.05 $100.00 → $90.00
2020-04-22 Buy Target Lowered by Citigroup $74.05 $120.00 → $100.00
2020-04-21 Buy Reiterated by Oppenheimer $76.51 $115.00
2020-04-17 Buy Target Lowered by Craig Hallum $74.65 $127.00 → $99.00

EXAS Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -16.57% during the next 3 months and, with a 90% probability hold a price between $63.16 and $78.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-12-10 $75.40 $84.63 $93.85
2021-12-13 $75.11 $84.33 $93.56
2021-12-14 $74.81 $84.04 $93.26
2021-12-15 $74.51 $83.74 $92.96
2021-12-16 $74.22 $83.44 $92.67
2021-12-17 $73.92 $83.15 $92.37
2021-12-20 $73.62 $82.85 $92.07
2021-12-21 $73.33 $82.55 $91.78
2021-12-22 $73.03 $82.26 $91.48
2021-12-23 $72.73 $81.96 $91.18
2021-12-27 $72.44 $81.66 $90.89
2021-12-28 $72.14 $81.36 $90.59
2021-12-29 $71.84 $81.07 $90.29
2021-12-30 $71.55 $80.77 $90.00
2021-12-31 $71.25 $80.47 $89.70
2022-01-03 $70.95 $80.18 $89.40
2022-01-04 $70.66 $79.88 $89.11
2022-01-05 $70.36 $79.58 $88.81
2022-01-06 $70.06 $79.29 $88.51
2022-01-07 $69.76 $78.99 $88.22
2022-01-10 $69.47 $78.69 $87.92
2022-01-11 $69.17 $78.40 $87.62
2022-01-12 $68.87 $78.10 $87.33
2022-01-13 $68.58 $77.80 $87.03
2022-01-14 $68.28 $77.51 $86.73
2022-01-17 $67.98 $77.21 $86.44
2022-01-18 $67.69 $76.91 $86.14
2022-01-19 $67.39 $76.62 $85.84
2022-01-20 $67.09 $76.32 $85.55
2022-01-21 $66.80 $76.02 $85.25

About EXACT Sciences Corporation

EXACT Sciences Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. Its Cologuard test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company has a collabor... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT